Research news
New technology reduces the profitability for new drugs
-
Correspondence: John K Borchardt jkborchardt@aol.com
Genome Biology 2001, 2:spotlight-20010412-03 doi:10.1186/gb-spotlight-20010412-03
Published: 12 April 2001The recent American College of Cardiology meeting provided a striking example of how combinatorial chemistry is changing the face of the drugs market.